OptiNose Receivables

OptiNose (OPTN) currently reports a receivables of $23M as of March 2025. That compares with $14M in the prior-year period — up 62.7% year over year. Use the charts on this page to explore OptiNose's receivables history and peer comparisons.

OptiNose's receivables increased from $14M to $23M — a 62.7% year-over-year increase (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

OptiNose reported $23M in receivables as of March 2025. That compares with $14M in the prior-year period — up 62.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OptiNose, and consider following OPTN for alerts when major investors trade the stock.

OptiNose is classified in the Healthcare sector. On receivables, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPTN with unrelated industries.